Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
- Resource Type
- Article
- Source
- Cancer Control: Journal of the Moffitt Cancer Center; 1/1/2022, Vol. 29, p1-11, 11p
- Subject
- Language
- ISSN
- 10732748